Table 7.
List of currently approved biosimilar monoclonal antibodies in oncology
| Region | Active substance | Brand name (pharmaceutical company) | Approved indications in oncology | Approval date |
|---|---|---|---|---|
| India | Trastuzumab | CANmab (Biocon)/Hertraz (Mylan) | HER2-positive breast cancer | 25/11/2013 |
| South Korea | Trastuzumab | Herzuma (Celltrion) | HER2-positive breast cancer Advanced (metastatic) gastric cancer |
15/01/2014 |
| Russia | Trastuzumab | HERtiCAD (Biocad) | Breast cancer | 20/01/2016 |
| Russia | Rituximab | AcellBia (CSJC biocad) | CD20-positive non-Hodgkin’s B-cell lymphoma | 25/05/2014 |
HER2 human epidermal growth factor receptor 2